Hmdb loader
Survey
You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:00:11 UTC
Update Date2020-02-26 21:39:07 UTC
HMDB IDHMDB0013845
Secondary Accession Numbers
  • HMDB13845
Metabolite Identification
Common NameSR 49498
DescriptionSR 49498 belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond. SR 49498 is an extremely weak basic (essentially neutral) compound (based on its pKa). SR 49498 is a metabolite of Irbesartan.
Structure
Data?1582753147
Synonyms
ValueSource
1-[(1-Hydroxypentylidene)amino]-N-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}cyclopentane-1-carboximidateGenerator
Chemical FormulaC25H30N6O2
Average Molecular Weight446.5447
Monoisotopic Molecular Weight446.243024234
IUPAC Name1-pentanamido-N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)cyclopentane-1-carboxamide
Traditional Name1-pentanamido-N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)cyclopentane-1-carboxamide
CAS Registry NumberNot Available
SMILES
CCCCC(=O)NC1(CCCC1)C(=O)NCC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1
InChI Identifier
InChI=1S/C25H30N6O2/c1-2-3-10-22(32)27-25(15-6-7-16-25)24(33)26-17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-28-30-31-29-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,26,33)(H,27,32)(H,28,29,30,31)
InChI KeyPAKGYCNZUGIDHV-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassBiphenyls and derivatives
Direct ParentBiphenyls and derivatives
Alternative Parents
Substituents
  • Biphenyl
  • Phenyltetrazole
  • Azole
  • Tetrazole
  • Heteroaromatic compound
  • Carboximidic acid
  • Carboximidic acid derivative
  • Propargyl-type 1,3-dipolar organic compound
  • Organic 1,3-dipolar compound
  • Organoheterocyclic compound
  • Azacycle
  • Organooxygen compound
  • Organopnictogen compound
  • Hydrocarbon derivative
  • Organic oxygen compound
  • Organic nitrogen compound
  • Organonitrogen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.0079 g/LALOGPS
logP3.56ALOGPS
logP4.39ChemAxon
logS-4.8ALOGPS
pKa (Strongest Acidic)7.4ChemAxon
pKa (Strongest Basic)0.064ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area112.66 ŲChemAxon
Rotatable Bond Count9ChemAxon
Refractivity139.56 m³·mol⁻¹ChemAxon
Polarizability48.98 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+208.23431661259
DarkChem[M-H]-204.27731661259
DeepCCS[M+H]+203.79330932474
DeepCCS[M-H]-201.43530932474
DeepCCS[M-2H]-234.79930932474
DeepCCS[M+Na]+210.5230932474
AllCCS[M+H]+209.032859911
AllCCS[M+H-H2O]+207.032859911
AllCCS[M+NH4]+210.932859911
AllCCS[M+Na]+211.432859911
AllCCS[M-H]-202.132859911
AllCCS[M+Na-2H]-203.232859911
AllCCS[M+HCOO]-204.532859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
SR 49498CCCCC(=O)NC1(CCCC1)C(=O)NCC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N14702.5Standard polar33892256
SR 49498CCCCC(=O)NC1(CCCC1)C(=O)NCC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N13664.7Standard non polar33892256
SR 49498CCCCC(=O)NC1(CCCC1)C(=O)NCC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N14117.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
SR 49498,1TMS,isomer #1CCCCC(=O)N(C1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)CCCC1)[Si](C)(C)C3818.4Semi standard non polar33892256
SR 49498,1TMS,isomer #1CCCCC(=O)N(C1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)CCCC1)[Si](C)(C)C3886.0Standard non polar33892256
SR 49498,1TMS,isomer #1CCCCC(=O)N(C1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)CCCC1)[Si](C)(C)C5555.7Standard polar33892256
SR 49498,1TMS,isomer #2CCCCC(=O)NC1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)[Si](C)(C)C)CCCC13807.1Semi standard non polar33892256
SR 49498,1TMS,isomer #2CCCCC(=O)NC1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)[Si](C)(C)C)CCCC13859.4Standard non polar33892256
SR 49498,1TMS,isomer #2CCCCC(=O)NC1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)[Si](C)(C)C)CCCC15352.0Standard polar33892256
SR 49498,1TMS,isomer #3CCCCC(=O)NC1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C2)CCCC14058.5Semi standard non polar33892256
SR 49498,1TMS,isomer #3CCCCC(=O)NC1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C2)CCCC13965.1Standard non polar33892256
SR 49498,1TMS,isomer #3CCCCC(=O)NC1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C2)CCCC15251.8Standard polar33892256
SR 49498,2TMS,isomer #1CCCCC(=O)N(C1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)[Si](C)(C)C)CCCC1)[Si](C)(C)C3739.1Semi standard non polar33892256
SR 49498,2TMS,isomer #1CCCCC(=O)N(C1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)[Si](C)(C)C)CCCC1)[Si](C)(C)C3818.9Standard non polar33892256
SR 49498,2TMS,isomer #1CCCCC(=O)N(C1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)[Si](C)(C)C)CCCC1)[Si](C)(C)C5159.0Standard polar33892256
SR 49498,2TMS,isomer #2CCCCC(=O)N(C1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C2)CCCC1)[Si](C)(C)C3985.6Semi standard non polar33892256
SR 49498,2TMS,isomer #2CCCCC(=O)N(C1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C2)CCCC1)[Si](C)(C)C3973.1Standard non polar33892256
SR 49498,2TMS,isomer #2CCCCC(=O)N(C1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C2)CCCC1)[Si](C)(C)C5125.0Standard polar33892256
SR 49498,2TMS,isomer #3CCCCC(=O)NC1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C2)[Si](C)(C)C)CCCC13967.4Semi standard non polar33892256
SR 49498,2TMS,isomer #3CCCCC(=O)NC1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C2)[Si](C)(C)C)CCCC13962.4Standard non polar33892256
SR 49498,2TMS,isomer #3CCCCC(=O)NC1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C2)[Si](C)(C)C)CCCC14950.2Standard polar33892256
SR 49498,3TMS,isomer #1CCCCC(=O)N(C1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C2)[Si](C)(C)C)CCCC1)[Si](C)(C)C3907.7Semi standard non polar33892256
SR 49498,3TMS,isomer #1CCCCC(=O)N(C1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C2)[Si](C)(C)C)CCCC1)[Si](C)(C)C3958.5Standard non polar33892256
SR 49498,3TMS,isomer #1CCCCC(=O)N(C1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C2)[Si](C)(C)C)CCCC1)[Si](C)(C)C4816.1Standard polar33892256
SR 49498,1TBDMS,isomer #1CCCCC(=O)N(C1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)CCCC1)[Si](C)(C)C(C)(C)C4007.6Semi standard non polar33892256
SR 49498,1TBDMS,isomer #1CCCCC(=O)N(C1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)CCCC1)[Si](C)(C)C(C)(C)C4097.5Standard non polar33892256
SR 49498,1TBDMS,isomer #1CCCCC(=O)N(C1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)CCCC1)[Si](C)(C)C(C)(C)C5487.6Standard polar33892256
SR 49498,1TBDMS,isomer #2CCCCC(=O)NC1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)[Si](C)(C)C(C)(C)C)CCCC14009.0Semi standard non polar33892256
SR 49498,1TBDMS,isomer #2CCCCC(=O)NC1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)[Si](C)(C)C(C)(C)C)CCCC14057.1Standard non polar33892256
SR 49498,1TBDMS,isomer #2CCCCC(=O)NC1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)[Si](C)(C)C(C)(C)C)CCCC15358.3Standard polar33892256
SR 49498,1TBDMS,isomer #3CCCCC(=O)NC1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C2)CCCC14174.9Semi standard non polar33892256
SR 49498,1TBDMS,isomer #3CCCCC(=O)NC1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C2)CCCC14194.1Standard non polar33892256
SR 49498,1TBDMS,isomer #3CCCCC(=O)NC1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C2)CCCC15206.9Standard polar33892256
SR 49498,2TBDMS,isomer #1CCCCC(=O)N(C1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)[Si](C)(C)C(C)(C)C)CCCC1)[Si](C)(C)C(C)(C)C4074.5Semi standard non polar33892256
SR 49498,2TBDMS,isomer #1CCCCC(=O)N(C1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)[Si](C)(C)C(C)(C)C)CCCC1)[Si](C)(C)C(C)(C)C4234.0Standard non polar33892256
SR 49498,2TBDMS,isomer #1CCCCC(=O)N(C1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C2)[Si](C)(C)C(C)(C)C)CCCC1)[Si](C)(C)C(C)(C)C5109.3Standard polar33892256
SR 49498,2TBDMS,isomer #2CCCCC(=O)N(C1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C2)CCCC1)[Si](C)(C)C(C)(C)C4281.0Semi standard non polar33892256
SR 49498,2TBDMS,isomer #2CCCCC(=O)N(C1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C2)CCCC1)[Si](C)(C)C(C)(C)C4407.4Standard non polar33892256
SR 49498,2TBDMS,isomer #2CCCCC(=O)N(C1(C(=O)NCC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C2)CCCC1)[Si](C)(C)C(C)(C)C5053.2Standard polar33892256
SR 49498,2TBDMS,isomer #3CCCCC(=O)NC1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C2)[Si](C)(C)C(C)(C)C)CCCC14277.9Semi standard non polar33892256
SR 49498,2TBDMS,isomer #3CCCCC(=O)NC1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C2)[Si](C)(C)C(C)(C)C)CCCC14381.0Standard non polar33892256
SR 49498,2TBDMS,isomer #3CCCCC(=O)NC1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C2)[Si](C)(C)C(C)(C)C)CCCC14956.0Standard polar33892256
SR 49498,3TBDMS,isomer #1CCCCC(=O)N(C1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C2)[Si](C)(C)C(C)(C)C)CCCC1)[Si](C)(C)C(C)(C)C4362.9Semi standard non polar33892256
SR 49498,3TBDMS,isomer #1CCCCC(=O)N(C1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C2)[Si](C)(C)C(C)(C)C)CCCC1)[Si](C)(C)C(C)(C)C4568.5Standard non polar33892256
SR 49498,3TBDMS,isomer #1CCCCC(=O)N(C1(C(=O)N(CC2=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C2)[Si](C)(C)C(C)(C)C)CCCC1)[Si](C)(C)C(C)(C)C4821.7Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - SR 49498 GC-MS (Non-derivatized) - 70eV, Positivesplash10-00kr-8951200000-84217b7414e4a7681d162017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - SR 49498 GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - SR 49498 10V, Positive-QTOFsplash10-03ds-2589800000-cd5d13c9ac5a69fc6cc72016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - SR 49498 20V, Positive-QTOFsplash10-0f79-4492100000-bdbe131c0f08d60f0a432016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - SR 49498 40V, Positive-QTOFsplash10-0a5i-9350000000-d9f69b7e4a8afcbde6ee2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - SR 49498 10V, Negative-QTOFsplash10-0002-1111900000-9bd3c260c5b6cb1339632016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - SR 49498 20V, Negative-QTOFsplash10-03dj-6565900000-43442353c63221a79d032016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - SR 49498 40V, Negative-QTOFsplash10-003r-9700000000-bb4da75abefb6468f1292016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - SR 49498 10V, Positive-QTOFsplash10-0002-0028900000-5b74cc500ea3d7c819f42021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - SR 49498 20V, Positive-QTOFsplash10-000b-7097100000-1584481b70d21d81f3962021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - SR 49498 40V, Positive-QTOFsplash10-052r-1190000000-5f91a08dcc3b293e13182021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - SR 49498 10V, Negative-QTOFsplash10-0002-0020900000-c6cfda36db5328178aa42021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - SR 49498 20V, Negative-QTOFsplash10-03fs-7938400000-a0f505ab35561f665bd02021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - SR 49498 40V, Negative-QTOFsplash10-004i-4910000000-e47d4881af60c77409112021-09-25Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Extracellular
Biospecimen Locations
  • Blood
  • Urine
Tissue Locations
  • Kidney
  • Liver
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound68617604
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available

Enzymes

General function:
Involved in transferase activity, transferring hexosyl groups
Specific function:
UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds.
Gene Name:
UGT1A3
Uniprot ID:
P35503
Molecular weight:
60337.835
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
General function:
Involved in peroxidase activity
Specific function:
May play an important role in regulating or promoting cell proliferation in some normal and neoplastically transformed cells.
Gene Name:
PTGS1
Uniprot ID:
P23219
Molecular weight:
68685.82
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide.
Gene Name:
CYP3A4
Uniprot ID:
P08684
Molecular weight:
57255.585
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan.
Gene Name:
CYP2C9
Uniprot ID:
P11712
Molecular weight:
55627.365
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  2. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants.
Gene Name:
CYP2D6
Uniprot ID:
P10635
Molecular weight:
55768.94
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Most active in catalyzing 2-hydroxylation. Caffeine is metabolized primarily by cytochrome CYP1A2 in the liver through an initial N3-demethylation. Also acts in the metabolism of aflatoxin B1 and acetaminophen. Participates in the bioactivation of carcinogenic aromatic and heterocyclic amines. Catalizes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin.
Gene Name:
CYP1A2
Uniprot ID:
P05177
Molecular weight:
58406.915
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti-cancer drug paclitaxel (taxol).
Gene Name:
CYP2C8
Uniprot ID:
P10632
Molecular weight:
55824.275
References
  1. Walsky RL, Gaman EA, Obach RS: Examination of 209 drugs for inhibition of cytochrome P450 2C8. J Clin Pharmacol. 2005 Jan;45(1):68-78. [PubMed:15601807 ]
  2. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in sequence-specific DNA binding transcription factor activity
Specific function:
Transcription factor that recognizes and binds to the enhancer heptamer motif 5'-TGA[CG]TCA-3'
Gene Name:
JUN
Uniprot ID:
P05412
Molecular weight:
35675.3
References
  1. Zhu ZS, Wang JM, Chen SL: Mesenteric artery remodeling and effects of imidapril and irbesartan on it in spontaneously hypertensive rats. World J Gastroenterol. 2004 May 15;10(10):1471-5. [PubMed:15133856 ]
  2. Cheng SM, Yang SP, Ho LJ, Tsao TP, Chang DM, Lai JH: Irbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1. Br J Pharmacol. 2004 Jul;142(6):933-42. Epub 2004 Jun 21. [PubMed:15210574 ]
General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
Receptor for angiotensin II. Mediates its action by association with G proteins that activate a phosphatidylinositol- calcium second messenger system
Gene Name:
AGTR1
Uniprot ID:
P30556
Molecular weight:
41060.5
References
  1. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
  2. Voigt JP, Bramlage P, Fink H: Hypophagic effect of the angiotensin AT1 receptor antagonist irbesartan in rats. Eur J Pharmacol. 2007 Jun 14;564(1-3):131-7. Epub 2007 Mar 3. [PubMed:17408613 ]
  3. Waeber B, Burnier M: AT1-receptor antagonism in hypertension: what has been learned with irbesartan? Expert Rev Cardiovasc Ther. 2003 May;1(1):23-33. [PubMed:15030294 ]
  4. Dol F, Martin G, Staels B, Mares AM, Cazaubon C, Nisato D, Bidouard JP, Janiak P, Schaeffer P, Herbert JM: Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice. J Cardiovasc Pharmacol. 2001 Sep;38(3):395-405. [PubMed:11486244 ]
  5. Martin G, Dol F, Mares AM, Berezowski V, Staels B, Hum DW, Schaeffer P, Herbert JM: Lesion progression in apoE-deficient mice: implication of chemokines and effect of the AT1 angiotensin II receptor antagonist irbesartan. J Cardiovasc Pharmacol. 2004 Feb;43(2):191-9. [PubMed:14716205 ]
  6. van den Meiracker AH, Admiraal PJ, Janssen JA, Kroodsma JM, de Ronde WA, Boomsma F, Sissmann J, Blankestijn PJ, Mulder PG, Man In 't Veld AJ, et al.: Hemodynamic and biochemical effects of the AT1 receptor antagonist irbesartan in hypertension. Hypertension. 1995 Jan;25(1):22-9. [PubMed:7843749 ]
  7. Carraway JW, Park S, McCune SA, Holycross BJ, Radin MJ: Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats. J Cardiovasc Pharmacol. 1999 Mar;33(3):451-60. [PubMed:10069682 ]
  8. Hope S, Brecher P, Chobanian AV: Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis. Am J Hypertens. 1999 Jan;12(1 Pt 1):28-34. [PubMed:10075381 ]
  9. Mazzolai L, Maillard M, Rossat J, Nussberger J, Brunner HR, Burnier M: Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists. Hypertension. 1999 Mar;33(3):850-5. [PubMed:10082498 ]
  10. Morsing P, Adler G, Brandt-Eliasson U, Karp L, Ohlson K, Renberg L, Sjoquist PO, Abrahamsson T: Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin. Hypertension. 1999 Jun;33(6):1406-13. [PubMed:10373224 ]
  11. Adams MA, Trudeau L: Irbesartan: review of pharmacology and comparative properties. Can J Clin Pharmacol. 2000 Spring;7(1):22-31. [PubMed:10822210 ]
  12. Croom KF, Plosker GL: Irbesartan: a review of its use in hypertension and diabetic nephropathy. Drugs. 2008;68(11):1543-69. [PubMed:18627212 ]
  13. Croom KF, Curran MP, Goa KL, Perry CM: Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy. Drugs. 2004;64(9):999-1028. [PubMed:15101793 ]